Creatine phosphate: pharmacological and clinical perspectives (Q37980661)

26 August 2017

Creatine phosphate: pharmacological and clinical perspectives (English)

1 reference

26 August 2017

1 reference

Ettore Strumia

1

1 reference

26 August 2017

Francesco Pelliccia

series ordinal

2

1 reference

26 August 2017

Giuseppe D'Ambrosio

series ordinal

3

1 reference

26 August 2017

language of work or name

English

0 references

publication date

1 February 2012

1 reference

26 August 2017

1 reference

26 August 2017

29

1 reference

26 August 2017

2

1 reference

26 August 2017

99-123

1 reference

https://scigraph.springernature.com/pub.10.1007/s12325-011-0091-4

26 August 2017

0 references

cites work

Transport of energy in muscle: the phosphorylcreatine shuttle

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0091-4

Is the failing heart energy starved? On using chemical energy to support cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0091-4

Metabolic energetics and genetics in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0091-4

Energy metabolism in heart failure and remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0091-4

Oxygen deprivation and early myocardial contractile failure: A reassessment of the possible role of adenosine triphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0091-4

High-energy phosphate metabolism and creatine kinase in failing hearts: a new porcine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0091-4

Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0091-4

Detection of myocardial ischemia by 31P magnetic resonance spectroscopy during handgrip exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0091-4

Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0091-4

Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0091-4

The relationship between plasma BNP level and the myocardial phosphocreatine/adenosine triphosphate ratio determined by phosphorus-31 magnetic resonance spectroscopy in patients with dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0091-4

Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0091-4

Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0091-4

The failing heart--an engine out of fuel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0091-4

Adaptive changes in the periphery and their therapeutic consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0091-4

Explaining fatigue in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0091-4

Skeletal muscle disorders in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0091-4

The response of isolated cardiac muscle to acute anoxia: protective effect of adenosine triphosphate and creatine phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0091-4

Protection of ischemic myocardium by exogenous phosphocreatine (neoton): pharmacokinetics of phosphocreatine, reduction of infarct size, stabilization of sarcolemma of ischemic cardiomyocytes, and antithrombotic action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0091-4

Respiratory control and the integration of heart high-energy phosphate metabolism by mitochondrial creatine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0091-4

Muscle AMP aminohydrolase. 3. A comparative study on the regulatory properties of skeletal muscle enzyme from various species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0091-4

Mechanisms Contributing to Malignant Dysrhythmias Induced by Ischemia in the Cat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0091-4

Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0091-4

Systems bioenergetics of creatine kinase networks: physiological roles of creatine and phosphocreatine in regulation of cardiac cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0091-4

Biochemical changes induced in the myocardial cell during cardioplegic arrest supplemented with creatine phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0091-4

Biochemical and Functional Effects of Creatine Phosphate in Cardioplegic Solution during Aortic Valve Surgery - a Clinical Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-011-0091-4

10.1007/S12325-011-0091-4

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference